60 studies found for:    s1007
Show Display Options
Rank Status Study
1 Recruiting Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: systemic chemotherapy;   Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: exemestane;   Drug: letrozole;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
2 Completed Study to Evaluate the Safety and Efficacy of S-297995 for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain
Condition: Opioid Induced Bowel Dysfunction
Interventions: Drug: 0.1 mg of S-297995 or placebo;   Drug: 0.3 mg of S-297995 or placebo;   Drug: 1 mg of S-297995 or placebo;   Drug: 3 mg of S-297995 or placebo;   Drug: 0.03 mg of S-297995 or placebo;   Drug: 0.01 mg of S-297995 or placebo
3 Completed A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: continuous infusion of 5-fluorouracil;   Drug: combination of irinotecan and cisplatin;   Drug: oral administration of S-1
4 Completed
Has Results
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
Condition: Neoplasms, Prostate
Interventions: Drug: Dutasteride;   Drug: Placebo
5 Recruiting (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: SAN-300;   Drug: Placebo
6 Recruiting Sientra Post-Approval Study
Conditions: Breast Augmentation;   Breast Reconstruction;   Breast Revision
Intervention:
7 Completed Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
Conditions: Diabetes Mellitus;   Asthma;   Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Human Insulin Inhalation Powder;   Drug: injected insulin
8 Recruiting Alemtuzumab and CHOP in T-cell Lymphoma
Condition: Lymphoma, T-Cell, Peripheral
Interventions: Drug: CHOP14 chemotherapy (cyclophosphamide, hydroxydaunorubicin, vincristin, prednison) plus G-CSF, combined with alemtuzumab;   Drug: CHOP14 chemotherapy (see specification under Arm B) plus G-CSF
9 Completed Study of Immunotherapy to Treat Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Ipilimumab;   Drug: Placebo
10 Completed Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects
Conditions: Acquired Bleeding Disorder;   Acquired Haemophilia;   Congenital Bleeding Disorder;   Congenital FVII Deficiency;   Glanzmann's Disease;   Haemophilia A With Inhibitors;   Haemophilia B With Inhibitors;   Healthy
Intervention: Drug: activated recombinant human factor VII
11 Completed LAS41005 in Hyperkeratotic Actinic Keratosis
Condition: Hyperkeratotic Actinic Keratosis
Interventions: Procedure: Cryotherapy;   Drug: LAS41005
12 Completed Tolerability and Pharmacokinetics of Metformin and Metformin Extended Release (ER)
Condition: Healthy
Interventions: Drug: metformin ER;   Drug: metformin
13 Completed ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: ACT-128800;   Drug: Placebo
14 Completed
Has Results
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
Conditions: Metabolism and Nutrition Disorder;   Obesity
Interventions: Drug: liraglutide;   Drug: placebo
15 Completed Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - Diabetes
Conditions: Metabolism and Nutrition Disorder;   Obesity
Interventions: Drug: liraglutide;   Drug: placebo
16 Unknown  Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: CHOP regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate
17 Completed Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: BCG vaccine;   Biological: monoclonal antibody BEC2
18 Active, not recruiting Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Condition: Acute Coronary Syndrome
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo
19 Recruiting Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Condition: Amyloidosis
Interventions: Drug: KIACTA (eprodisate disodium);   Drug: Placebo
20 Completed An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults
Conditions: Bacterial Infections;   Staphylococcal Vaccines;   Immunotherapy, Active;   Staphylococcal Skin Infections;   Staphylococcal Infections
Interventions: Biological: SA3Ag vaccine;   Procedure: Blood draw;   Procedure: Colonization swab samples;   Biological: SA3Ag followed by Placebo;   Biological: Placebo;   Biological: SA3Ag with no booster in stage 2;   Procedure: Placebo with no booster in stage 2

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years